SOD1 and amyotrophic lateral sclerosis: The SOD1 variant-effect maps we provide could have immediate value: for a symptomatic person with a SOD1 variant that would otherwise be classified as VUS, our functional evidence could help confirm an early ALS diagnosis that was otherwise lacking definitive support, thus enabling therapy that is earlier therapeutic intervention that is more tailored to SOD1-ALS.